BACKGROUND: Treatment failure of antiretroviral therapy in HIV-1 infection is increasing due to development of viral resistance. Trends of resistance-associated mutation lead to the ineffective treatment in HIV-infected individuals. METHODS: Extracted viral RNA from HIV-infected subjects in 2009 to 2010 was performed. The genotypic resistance testing was investigated for HIV-1 drug resistance in RT and PR genes. Frequencies of mutation were compared by a Fischer's exact test. RESULTS: Three hundred and sixty-nine samples (147 in 2009 and 222 in 2010) were genotyped. At least one mutation was found in 90.8% (335/369) in PR gene and 87.0% (321/369) in RT gene. Three sequences in PR gene, M36I, H69K, and L90M, were decreased significantly in 2010 when compared to 2009. Mutations associated with resistance to nucleoside analogue reverse transcriptase inhibitors (NRTI's) were found in 61.0% and 64.2% in nonnucleoside analogue reverse transcriptase inhibitors (NNRTI's). A total of 49.6% was found in combined NRTI and NNRTI. In 2010, M41L was increased significantly from 7.5% to 14.9%. However, there was a decrease in the frequency of the mutations at position 67, 70, and 184 between 2009 and 2010. CONCLUSIONS: In 2010, three mutations in PR gene, M36I, H69K, and L90M, were decreased significantly. However, only one mutation in RT gene, M41L was significantly increased.
BACKGROUND: Treatment failure of antiretroviral therapy in HIV-1 infection is increasing due to development of viral resistance. Trends of resistance-associated mutation lead to the ineffective treatment in HIV-infected individuals. METHODS: Extracted viral RNA from HIV-infected subjects in 2009 to 2010 was performed. The genotypic resistance testing was investigated for HIV-1 drug resistance in RT and PR genes. Frequencies of mutation were compared by a Fischer's exact test. RESULTS: Three hundred and sixty-nine samples (147 in 2009 and 222 in 2010) were genotyped. At least one mutation was found in 90.8% (335/369) in PR gene and 87.0% (321/369) in RT gene. Three sequences in PR gene, M36I, H69K, and L90M, were decreased significantly in 2010 when compared to 2009. Mutations associated with resistance to nucleoside analogue reverse transcriptase inhibitors (NRTI's) were found in 61.0% and 64.2% in nonnucleoside analogue reverse transcriptase inhibitors (NNRTI's). A total of 49.6% was found in combined NRTI and NNRTI. In 2010, M41L was increased significantly from 7.5% to 14.9%. However, there was a decrease in the frequency of the mutations at position 67, 70, and 184 between 2009 and 2010. CONCLUSIONS: In 2010, three mutations in PR gene, M36I, H69K, and L90M, were decreased significantly. However, only one mutation in RT gene, M41L was significantly increased.
Authors: C Tamalet; C Pasquier; N Yahi; P Colson; I Poizot-Martin; G Lepeu; H Gallais; P Massip; J Puel; J Izopet Journal: J Med Virol Date: 2000-06 Impact factor: 2.327
Authors: S A Wegner; S K Brodine; J R Mascola; S A Tasker; R A Shaffer; M J Starkey; A Barile; G J Martin; N Aronson; W W Emmons; K Stephan; S Bloor; J Vingerhoets; K Hertogs; B Larder Journal: AIDS Date: 2000-05-26 Impact factor: 4.177
Authors: S Duwe; M Brunn; D Altmann; O Hamouda; B Schmidt; H Walter; G Pauli; C Kücherer Journal: J Acquir Immune Defic Syndr Date: 2001-03-01 Impact factor: 3.731
Authors: Annemarie M J Wensing; David A van de Vijver; Gioacchino Angarano; Birgitta Asjö; Claudia Balotta; Enzo Boeri; Ricardo Camacho; Maire-Laure Chaix; Dominique Costagliola; Andrea De Luca; Inge Derdelinckx; Zehava Grossman; Osamah Hamouda; Angelos Hatzakis; Robert Hemmer; Andy Hoepelman; Andrzej Horban; Klaus Korn; Claudia Kücherer; Thomas Leitner; Clive Loveday; Eilidh MacRae; Irina Maljkovic; Carmen de Mendoza; Laurence Meyer; Claus Nielsen; Eline L Op de Coul; Vidar Ormaasen; Dimitris Paraskevis; Luc Perrin; Elisabeth Puchhammer-Stöckl; Lidia Ruiz; Mika Salminen; Jean-Claude Schmit; Francois Schneider; Rob Schuurman; Vincent Soriano; Grzegorz Stanczak; Maja Stanojevic; Anne-Mieke Vandamme; Kristel Van Laethem; Michela Violin; Karin Wilbe; Sabine Yerly; Maurizio Zazzi; Charles A Boucher Journal: J Infect Dis Date: 2005-08-15 Impact factor: 5.226
Authors: Jurgen Vercauteren; Annemarie M J Wensing; David A M C van de Vijver; Jan Albert; Claudia Balotta; Osamah Hamouda; Claudia Kücherer; Daniel Struck; Jean-Claude Schmit; Birgitta Asjö; Marie Bruckova; Ricardo J Camacho; Bonaventura Clotet; Suzie Coughlan; Zehava Grossman; Andrzej Horban; Klaus Korn; Leondios Kostrikis; Claus Nielsen; Dimitrios Paraskevis; Mario Poljak; Elisabeth Puchhammer-Stöckl; Chiara Riva; Lidia Ruiz; Mika Salminen; Rob Schuurman; Anders Sonnerborg; Danica Stanekova; Maja Stanojevic; Anne-Mieke Vandamme; Charles A B Boucher Journal: J Infect Dis Date: 2009-11-15 Impact factor: 5.226
Authors: Christopher J Hoffmann; Salome Charalambous; John Sim; Joanna Ledwaba; Graham Schwikkard; Richard E Chaisson; Katherine L Fielding; Gavin J Churchyard; Lynn Morris; Alison D Grant Journal: Clin Infect Dis Date: 2009-12-15 Impact factor: 9.079
Authors: Yiping Li; Qinjian Wang; Shu Liang; Dan Yuan; Shujuan Yang; Chuanteng Feng; Hong Yang; Hang Yu Journal: JMIR Public Health Surveill Date: 2022-06-24
Authors: Awachana Jiamsakul; Somnuek Sungkanuparph; Matthew Law; Rami Kantor; Jutarat Praparattanapan; Patrick C K Li; Praphan Phanuphak; Tuti Merati; Winai Ratanasuwan; Christopher K C Lee; Rossana Ditangco; Mahiran Mustafa; Thida Singtoroj; Sasisopin Kiertiburanakul Journal: J Int AIDS Soc Date: 2014-08-19 Impact factor: 5.396